PAH Polyclonal Antibody

PAH encodes the enzyme phenylalanine hydroxylase that is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria.

The PAH Polyclonal Antibody is a highly specific and reliable tool designed for the detection and quantification of phenylalanine hydroxylase (PAH) protein in various biological samples. This antibody has been meticulously developed using advanced techniques to ensure exceptional sensitivity and specificity.

Phenylalanine hydroxylase is a crucial enzyme involved in the metabolism of the amino acid phenylalanine. Mutations in the PAH gene can lead to phenylketonuria (PKU), a metabolic disorder characterized by the inability to properly break down phenylalanine. The PAH Polyclonal Antibody enables researchers to investigate the expression and regulation of PAH in both normal and disease states.

This antibody exhibits outstanding performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes the PAH protein with high affinity, allowing for accurate and precise detection even at low expression levels. The PAH Polyclonal Antibody is compatible with various sample types, including cell lysates, tissue homogenates, and serum.

With its exceptional quality and reliability, the PAH Polyclonal Antibody is an indispensable tool for researchers studying phenylalanine metabolism, PKU, and related disorders. Its robust performance and versatility make it an ideal choice for both basic research and clinical investigations. Trust in the PAH Polyclonal Antibody to provide accurate and reproducible results, advancing your understanding of PAH biology and contributing to the development of novel therapeutic strategies.